Search:

Filter:

Post type:

Sort:

October 19, 2026: Two deaths linked to bootlegged of retatrutide

October 21, 2026

Two deaths have been linked to black market versions of retatrutide, as a British woman warns followers that taking an early dose of the drug “nearly killed” her.

Partnership for Safe Medicines files Citizen Petition urging FDA to block compounding of unapproved and uncharacterized peptides

October 21, 2026

The Partnership for Safe Medicines (PSM) filed a citizen petition urging the U.S. Food and Drug Administration to block compounding of unapproved peptides and to disregard the advisory committee vote that recommended allowing them.

PSM files Citizen Petition with FDA to stop unsafe compounding of untested peptides

October 21, 2026

Partnership for Safe Medicines filed a citizen petition (CP) with the FDA asking them to refrain from taking action to allow for compounding of drug products using seven peptide bulk drug substances (BPC-157, KPV, TB-500, MOTS-c, emideltide, semax, and epitalon). Learn why here.

October 13, 2026: Mounting evidence that popular unapproved peptide causes cancers

October 15, 2026

Doctors reported that a man who injected the unregulated peptide he purchased at a gym developed a melanoma lesion after only taking the drug for five weeks.

Remembering Alex Boutin: the hidden risks of performance enhancing drugs

October 14, 2026

Alex took the advice of older gym veterans about how he could bulk up fast, setting off more than a decade of steroid and, eventually, unregulated peptide use.

Judgment, USA v Brandon Piper

October 13, 2026

United States District Court Western District of Michigan Southern Division USA v Brandon Piper Judgment July 24, 2026 Read the document.

Plea agreement, USA v Brandon Piper

October 13, 2026

United States District CourtWestern District of MichiganSouthern Division USA v Brandon Piper Plea Agreement February 27, 2026 Read the document.

Update on drug importation, October 2026

October 9, 2026

Well-meaning advocates continue to propose importing medicine from foreign countries to lower drug prices for Americans. Past efforts didn’t pay off financially and raised public health risks. Here’s the state of this issue today.

October 5, 2026: Two charged in connection with fake Ozempic that spurred FDA public alert

October 7, 2026

According to court documents, from at least July 2023 to April 2024, the men allegedly obtained the counterfeit products, which included the packaging, pen labels, and needles, from unauthorized sources in China.

U.S. sentencing memo for Jennifer Stechkober, USA v Matthew J Kawa, et al., July 2026

September 30, 2026

United States District Court Northern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Jennifer Stechkober   Filed July 2026 Read the document.